When the Story We Tell Ourselves Gets Stuck: Resetting Meaning Making with Ketamine Therapy
Resetting meaning-making in psychiatry involves creating the biological conditions for the brain to break free from rigid, negative narratives. It’s not about forcing positive thoughts, but about using targeted treatments to enhance neuroplasticity, allowing for new, more adaptive perspectives to form and take root.
Your Brain Isn't Broken – It May Be Stuck in a Narrative Loop
In the landscape of mental health, we often talk about symptoms – low mood, lack of motivation, persistent anxiety. But beneath these symptoms lies a more fundamental process: the story we tell ourselves about who we are and what our experiences mean. For individuals facing conditions like treatment-resistant depression, this internal narrative can become a debilitating loop, reinforcing feelings of hopelessness and futility. Your brain isn’t broken – it may simply be stuck.
This "stuckness" has a biological correlation. It’s closely linked to a brain circuit called theDefault Mode Network (DMN). The DMN is a network of interacting brain regions that helps us interpret our relationship with the world around us and also serves as the seat of our self-referential thoughts, our daydreams, and our sense of self. In a healthy state, it’s flexible. But in conditions like depression, the DMN can become overactive and rigid, trapping a person in cycles of rumination and negative self-talk.[5] As a 2017 study in Chronic Stress highlights, this hyperactivity is a key feature of depressive rumination.
The Biological Basis of a Fixed Mindset
The inability to change one’s narrative isn’t a failure of willpower; it’s often a matter of biology. The brain’s ability to change, adapt, and form new connections is called neuroplasticity. This process, essential for learning and recovery, can be significantly dampened by chronic stress and depression. The brain literally becomes less capable of forging new pathways, making it feel impossible to think or feel differently. The very architecture of the brain reinforces the stuck narrative.
Dr. Ben Yudkoff, Chief Medical Officer at Lumin Health, notes, “We cannot simply tell a brain that has lost its plasticity to ‘think differently.’ It’s like telling someone with a broken leg to just walk it off. The goal of modern psychiatric intervention is to first create a biological window of opportunity – to restore the capacity for change so that new meaning can actually emerge.”
Creating a Window for Change: The Role of Neuroplastic Interventions
This is where emerging, evidence-informed treatments are changing the conversation. Rather than just managing symptoms, these interventions aim to directly target the biological roots of "stuckness." By rapidly promoting neuroplasticity, they can create a temporary but powerful window where the brain is more flexible, more receptive to change, and less constrained by the rigid patterns of the DMN. At our practice, we see this potential in both off-label ketamine therapy and FDA-approved Spravato.
These treatments work on the glutamate system, the brain's primary excitatory neurotransmitter. A medically-supervised dose can trigger a surge of glutamate, which in turn leads to what researchers call synaptogenesis – the literal sprouting of new connections between neurons. This process can happen within hours, a stark contrast to traditional antidepressants which can take weeks or months to have an effect.[1] This rapid rewiring is fundamental to helping patients find relief from severe depression and is a core focus of the care provided at Lumin Health.
How Neuroplastic Treatments Can Interrupt Rigid Brain Patterns
A treatment like intramuscular (IM) ketamine for depression or intranasal esketamine (Spravato) can help reset the meaning-making process by creating specific neurological shifts. The experience at our Lumin Health center is designed around this science.
The Process of Rebuilding Meaning: A Step-by-Step Perspective
Resetting one's internal narrative is a collaborative process between the patient and our psychiatrist-led care team. While every journey is unique, the underlying steps often follow a clear path supported by our specific care model.
Your Partner in Exploring a New Path Forward
If you feel trapped in a narrative that no longer serves you, please know that there are scientifically-grounded paths toward change. The goal is not to erase your story, but to empower you with the biological tools to write the next chapter. The psychiatrist-led, academically-affiliated leadership at our Boston-based practice is dedicated to providing this highly personalized, attentive care.
We would be grateful to walk with you towards relief. Explore whether the thoughtful and medically-rigorous approach to ketamine treatment at our organization may be a fit for your journey.
References
- Li N, Lee B, Liu RJ, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 2010;329(5994):959-64. PubMed
- Murrough JW, Soleimani L, DeWilde KE, et al. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Psychol Med. 2015;45(16):3571-80. PubMed
- Popova V, Daly EJ, Trivedi M, et al. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study. Am J Psychiatry. 2019;176(6):428-438. PubMed
- Fu DJ, Ionescu DF, Li X, et al. Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I). J Clin Psychiatry. 2020;81(3). PubMed
- Hamilton JP, Farmer M, Fogelman P, et al. Depressive Rumination, the Default-Mode Network, and the Dark Matter of Clinical Neuroscience. Biol Psychiatry. 2015;78(4):224-30. PubMed
Find out if ketamine therapy is covered by your plan.
Lumin Health accepts most major insurance providers for Spravato treatment in Massachusetts and the greater Washington DC/Maryland area. Use our free tool to check your coverage instantly — no forms, no phone calls.
Available in Massachusetts and the greater Washington DC/Maryland area.
Frequently Asked Questions
What does it mean to "reset" with ketamine therapy?
Resetting means creating the biological conditions for your brain to loosen a stuck, negative narrative, not simply thinking more positively. Ketamine therapy and esketamine (Spravato) can trigger a surge in the brain's glutamate system that supports forming new connections, opening a window where new perspectives become possible. It does not erase your story, but it may help you write a new chapter.
What is the Default Mode Network and why does it matter for depression?
The Default Mode Network is the brain circuit behind your sense of self, daydreams and self-referential thought. In depression it can become overactive and rigid, trapping you in rumination and negative self-talk. Ketamine therapy and esketamine (Spravato) may help loosen that rigidity so more adaptive perspectives can emerge.
How quickly can ketamine therapy change the brain?
Research suggests the glutamate surge triggered by ketamine therapy or esketamine (Spravato) can prompt the brain to grow new connections within hours. That is much faster than traditional antidepressants, which can take weeks or months to work. At Lumin Health, this rapid window is central to how care approaches severe depression.
What is the difference between esketamine (Spravato) and ketamine therapy for resetting stuck patterns?
Esketamine (Spravato) is a specific molecule given as a nasal spray and is FDA-approved for adults with treatment-resistant depression and major depression with suicidal thoughts. Ketamine therapy uses the full ketamine molecule and is an off-label, evidence-based option, given at Lumin Health as an intramuscular (IM) injection. Both act on the glutamate system to support neuroplasticity, and your care team helps determine which may be the right fit.
